Reset filters
  • 13 April 2016

$300 hepatitis C combination to enter clinical trials

Read the article
  • 12 April 2016

Primary care doctors and nurse practitioners can successfully treat people with hepatitis C

Read the article
  • 14 March 2016

Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals

Read the article
Erik Mogalian at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 8 March 2016

Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4

Read the article
Imam Waked presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 26 February 2016

Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low

Read the article
Jurgen Rockstroh presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com
  • 19 February 2016

Direct-acting antivirals reduce cryoglobulinemia in hepatitis C

Read the article
  • 1 February 2016

New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

Read the article
  • 30 December 2015

DAAs could halt HCV epidemic in US – but only with near-universal testing and big increase in treatment rates

Read the article
  • 29 December 2015

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but most successfully appeal

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.